Skip to main content
THERACRYF PLC logo

THERACRYF PLC — Investor Relations & Filings

Ticker · TCF ISIN · GB00BSVYN304 LEI · 213800NO3E6TSTQO8K20 IL Professional, scientific and technical activities
Open in API
Filings indexed 362 across all filing types
Latest filing 2018-09-11 Regulatory Filings
Country GB United Kingdom
Listing IL TCF

About THERACRYF PLC

https://theracryf.com/

TheraCryf PLC is a clinical-stage therapeutics company focused on developing a new generation of innovative medicines for behavioural brain disorders and oncology. The company's research and development efforts are centered on sulforaphane-based compounds. Its primary therapeutic focus is on conditions such as opioid and alcohol abuse, binge eating disorder, anxiety, and fatigue. TheraCryf's business strategy is to generate compelling clinical data for its drug candidates with the goal of partnering its programs with larger pharmaceutical companies for late-stage development and commercialization.

Recent filings

Filing Released Lang Actions
Notice of Investor Symposium
Regulatory Filings Classification · 98% confidence The document is an announcement from Evgen Pharma PLC regarding an upcoming 'Investor Symposium'. It provides details about the event, such as the date, location, and speakers, and explicitly states that 'No new material trading information will be disclosed'. Since it is a short announcement (under 5,000 characters) regarding a corporate event/presentation rather than the presentation itself, and it is distributed via the RNS (Regulatory News Service), it falls under the category of a general regulatory announcement.
2018-09-11 English
Group of companies' accounts made up to 2018-03-31
Regulatory Filings
2018-08-13 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Results of AGM' and explicitly states that 'all resolutions were duly passed at its Annual General Meeting'. This falls under the category of reporting the outcome of shareholder voting at a general meeting.
2018-07-26 English
AGM Statement
AGM Information Classification · 98% confidence The document is an 'AGM Statement' released via RNS (Regulatory News Service) by Evgen Pharma plc. It contains the Chairman's remarks prepared for the Annual General Meeting. While it is an announcement related to the AGM, it specifically contains the content of the Chairman's statement presented at the meeting, fitting the definition of AGM-R (Presentations and materials shared during the Annual General Meeting).
2018-07-26 English
Grant of share options, issue of equity and TVR
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from Evgen Pharma PLC. It covers three distinct regulatory events: the grant of share options to a person discharging managerial responsibilities (PDMR), the issuance of new equity following an option exercise, and a notification of total voting rights. While it contains elements of Director's Dealing (DIRS) and Share Issue (SHA), the document is a consolidated regulatory announcement provided via the London Stock Exchange's RNS platform. Given the multi-faceted nature of the announcement and its primary function as a regulatory disclosure, 'RNS' is the most accurate classification.
2018-07-10 English
Hardman & Co Research: Evgen Pharma (EVG): 2018, a pivotal year
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 5,000 characters) from Hardman & Co regarding the publication of a research report on Evgen Pharma. It explicitly provides a link to download the full report ('Please click here for the full report'). According to the 'Menu vs Meal' rule, this is an announcement of a report rather than the report itself, making it a Report Publication Announcement (RPA).
2018-06-29 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.